- In the midst of a major health emergency - widespread COVID-19 - researchers were able to conduct a well-designed study of remdesivir vs. placebo. Here are some ...
- In the UK, scientists have established the Recovery trial to test several treatments for SARS-CoV-2 infection. A preliminary analysis has found that some people ...
- One of the medicines that has been undergoing extensive testing in people with COVID-19 is a fixed-dose formulation of two drugs: lopinavir + ritonavir. In ...
- Individual drugs that are approved to treat a well-known virus and which are then repurposed to treat a new and sometimes unrelated virus will likely have only ...
- Scientists at the Emory Institute of Drug Development (EIDD) at Emory University in Atlanta have developed an antiviral drug they called EIDD-2801. This drug is ...
- As mentioned earlier in this issue of TreatmentUpdate, doctors are repurposing many medicines to find ones that have potential for preventing and treating ...
- One part of the immune system, called the innate immune system, can usually detect and respond to invading germs, including viruses, in the early stages of an ...
- Scientists in the UK are running a large clinical trial called Recovery, which involves testing different therapies for the treatment of COVID-19. In early ...
- Chloroquine (CQ) and its analogue, hydroxychloroquine (HCQ), have been used for many years to prevent and treat malaria. Both drugs can reduce the production of ...
- In the early days of the first wave of the COVID-19 pandemic, doctors in Canada and the U.S cooperated and launched a randomized, double-blind, ...
- The SARS-CoV-2 virus is responsible for a global pandemic. Some people infected with this virus will develop complications called COVID-19. As SARS-CoV-2 is new ...
- Researchers in the U.S. and other countries have identified that a combination of two drugs - tenofovir DF (TDF) + FTC - has antiviral potential against ...